There is no identified time interval for when NAION may develop following treatment start
For semaglutide doses, the volume loss from dead space at starting doses is proportionally larger, making low dead space syringes especially worthwhile early in the protocol
To view or add a comment, sign in Obesity care is entering a new era and Withings Health Solutions is leading the way
Julius Few to address the unique skin concerns experienced by GLP-1 medication users
NAD+ Semaglutide Timing: Method Comparison This comparison table was derived from clinical pharmacokinetics data on sirtuin modulators and GLP-1 agonists, patient-reported outcomes from TrimRx's supervised protocols, and absorption studies on subcutaneous peptide administration published in The Journal of Clinical Endocrinology & Metabolism
From there, theyll work with you to decide on a safe, evidence-based plan and discuss what to expect from treatment